Table 1.
An overview on recently reported nanomaterial-based electrochemical methods for the determination of covid-19
Materials used | Target biomarker | Clinical sample | Electrochemical method | LOD | Reference |
---|---|---|---|---|---|
AuNPs on paper electrode | RNA of the N gene | Nasopharyngeal sample | Current−voltage data collected using a homemade circuit | 6.9 copies/μL | [23] |
Redox dye-incorporated silica nanoparticles | N and S genes | RNA from Nasopharyngeal sample | Isothermal rolling circle amplification-Sandwich hybridization assay with differential pulse voltammetry | 1 copy/μL | [24] |
Cobalt-TiO2 nanotubes | S-RBD | Nasal and saliva samples | Amperometric detection | 14 nM | [25] |
Graphene oxide paper-based electrode | SARS-CoV-2 IgG, IgM and S protein | Serum | Label-free detection-SWV | 0.11 ng.mL−1 for spike protein | [26] |
Molecular imprinted polymer | N antigen | Nasopharyngeal samples | Differential pulse voltammetry | 15 fM | [28] |
Magnetic nanobeads | N antigen | Serum | Amperometric detection | 230 pg.mL−1 | [29] |
Magnetic beads with carbon black | S and N antigens | Saliva and nasopharyngeal sample | Differential pulse voltammetry | 19 ng.mL−1 and 8 ng.mL−1 | [30] |
Carbon nanofiber | N antigen | Nasopharyngeal sample | Competitive detection using SWV | 0.8 pg.mL−1 | [31] |
AuNPs | N antigen | Nasopharyngeal sample | Label-free detection using SWV | 0.4 pg.mL−1 | This work |